daidzein (soy)

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• Alzheimer dementia [Insufficient Evidence]
• asthma [Insufficient Evidence]
• BPH [Possibly Ineffective]
• cancer prevention, breast [Possibly Effective]
• cancer prevention, cervical [Insufficient Evidence]
• cancer prevention, colorectal [Possibly Ineffective]
• cancer prevention, endometrial [Insufficient Evidence]
• cancer prevention, gastric [Insufficient Evidence]
• cancer prevention, lung [Insufficient Evidence]
• cancer prevention, thyroid [Insufficient Evidence]
• cardiovascular dz prevention [Insufficient Evidence]
• child growth [Insufficient Evidence]
• CKD [Possibly Effective]
• cognitive function [Insufficient Evidence]
• cognitive impairment [Insufficient Evidence]
• colic [Insufficient Evidence]
• Crohn dz [Insufficient Evidence]
• diabetes mellitus [Possibly Effective]
• diabetic nephropathy [Insufficient Evidence]
• diarrhea [Possibly Effective]
• dyspepsia [Insufficient Evidence]
• exercise-induced muscle soreness [Possibly Ineffective]
• fibromyalgia [Insufficient Evidence]
• galactosemia [Possibly Effective]
• hepatitis C [Insufficient Evidence]
• hot flashes, androgen deprivation tx-assoc. [Insufficient Evidence]
• hot flashes, breast CA-assoc. [Possibly Ineffective]
• HTN [Possibly Effective]
• hyperlipidemia [Possibly Effective]
• IBS [Insufficient Evidence]
• lactose intolerance [Possibly Effective]
• mastalgia [Insufficient Evidence]
• menopausal sx [Possibly Effective]
• menstrual migraine prophylaxis [Insufficient Evidence]
• metabolic syndrome [Possibly Effective]
• muscle strength [Possibly Effective]
• neonatal jaundice prevention [Insufficient Evidence]
• nonalcoholic fatty liver dz [Insufficient Evidence]
• obesity [Insufficient Evidence]
• osteoarthritis [Insufficient Evidence]
• osteoporosis [Possibly Effective]
• overall mortality [Insufficient Evidence]
• polycystic ovary syndrome [Insufficient Evidence]
• postmenopausal conditions [Insufficient Evidence]
• premenstrual syndrome [Insufficient Evidence]
• preterm labor prevention [Insufficient Evidence]
• prostate CA [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• sarcopenia [Insufficient Evidence]
• stroke [Insufficient Evidence]
• vaginal atrophy [Insufficient Evidence]
• wrinkled skin [Insufficient Evidence]